Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Genetron Holdings Limited (GTH)

10.22   0.07 (0.69%) 09-29 00:30
Open: 10.35 Pre. Close: 10.15
High: 10.595 Low: 10.01
Volume: 48,684 Market Cap: 903M

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 10.618 - 10.669 10.669 - 10.715
Low: 9.888 - 9.946 9.946 - 9.998
Close: 10.125 - 10.22 10.22 - 10.306

Technical analysis

as of: 2020-09-28 4:33:21 PM
Stoxline posted a NEUTRAL today, same as yesterday. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 13.71     One year: 15.66
Support: Support1: 9.03    Support2: 7.51
Resistance: Resistance1: 11.73    Resistance2: 13.40
Pivot: 11.05
Moving Average: MA(5): 10.00     MA(20): 11.32
MA(100): 10.23     MA(250): 5.23
MACD: MACD(12,26): -0.70     Signal(9): -0.57
Stochastic oscillator: %K(14,3): 23.40     %D(3): 12.17
RSI: RSI(14): 37.21
52-week: High: 17.71  Low: 1.80  Change(%): 443.6
Average Vol(K): 3-Month: 18570  10-Days: 6929

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.
GTH has closed above bottom band by 24.8%. Bollinger Bands are 32.6% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Fri, 25 Sep 2020
Genetron Health and CStone Pharmaceuticals Announce Launch of Clinical Trial in China for Companion Diagnostic Test in Development for Avapritinib - GlobeNewswire

Thu, 24 Sep 2020
The Daily Biotech Pulse: Gilead's $7.25B Debt Offering, Lexicon Deleverages, Taysha Gene Therapies Prices IPO - Benzinga

Tue, 08 Sep 2020
Genetron Health to Present at Upcoming Investor Conferences - GlobeNewswire

Thu, 06 Aug 2020
Genetron Health Reports Second Quarter 2020 Unaudited Financial Results - GlobeNewswire

Mon, 27 Jul 2020
Genetron Health to Announce Second Quarter Unaudited Financial Results and Host Investor Call on August 6, 2020 - GlobeNewswire

Fri, 19 Jun 2020
Genetron Holdings Limited Rings the Nasdaq Stock Market Opening Bell in Celebration of its IPO - Nasdaq

Financial Analysis

Growth NA
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability NA
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency NA
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency NA
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Neutral Discounted cash flow: Neutral
Return on Assets: Neutral Price to Earnings: Neutral
Return on Equity: Neutral Debt to Equity: Neutral
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Shares Out. (M) 88
Shares Float (M) 12
% Held by Insiders
% Held by Institutions
Shares Short (K) 310
Shares Short P. Month (K) 274

Stock Financials

EPS Est This Year
EPS Est Next Year
Book Value (p.s.)
Profit Margin
Operating Margin
Return on Assets (ttm)
Return on Equity (ttm)
Qtrly Rev. Growth 40.3
Gross Profit (p.s.) 1.641
Sales Per Share
EBITDA (p.s.)
Qtrly Earnings Growth
Operating Cash Flow (M)
Levered Free Cash Flow (M)

Stock Valuations

PE Ratio
PEG Ratio
Price to Book value
Price to Sales
Price to Cash Flow

Stock Dividends

Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2020 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.